Innovating Works

EVOTEC INTERNATIONAL GMBH

Desconocido
ProgRet: European Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases EVOTEC INTERNATIONAL GMBH participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 ProgRET will create a multidisciplinary and intersectoral European training network focusing on the mechanisms, diagnosis and therapy of dom...
2023-07-05 - 2027-12-31 | Financiado
TALENTS: Training AlliancE for Novel Microbiome-Modulating TherapieS EVOTEC INTERNATIONAL GMBH participó en un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 doctoral candidates (DCs) as nee...
2022-09-02 - 2027-12-31 | Financiado
Chrom_rare: Unveiling the molecular basis of chromatinopathies to delineate innovative therapeutic solutions EVOTEC INTERNATIONAL GMBH participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Chromatinopathies (CPs) are a group of rare genetic diseases, which share clinical features as well as causal genetic alterations, leading t...
2022-06-14 - 2026-12-31 | Financiado
ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS EVOTEC INTERNATIONAL GMBH participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado
COMBINE: Collaboration for Prevention and Treatment of MDR Bacterial Infections EVOTEC INTERNATIONAL GMBH participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The loss of antibiotic effectiveness due to increasing antimicrobial resistance (AMR) is a serious threat to global public health. The IMI2...
2019-11-27 - 2025-10-31 | Financiado
GNA NOW: NOVEL GRAM NEGATIVE ANTIBIOTIC NOW EVOTEC INTERNATIONAL GMBH participó en un H2020: H2020-JTI-IMI2-2018-16-single-stage AntiMicrobial Resistance (AMR) is a global and serious threat to human health. Gram-negative bacteria are widely regarded as the culprit rep...
2019-06-17 - 2025-12-31 | Financiado
NEUROMODEL: Initial Training Network on therapeutic approaches and predictive models for neurodegenerative disea... EVOTEC INTERNATIONAL GMBH participó en un FP7: Neurodegenerative diseases such as Parkinson’s disease (PD) and Huntington’s disease (HD) still lack treatments that are disease modifyi...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.